Structural basis of suppression of host translation termination by Moloney Murine Leukemia Virus
Retroviral reverse transcriptase from Moloney Murine Leukemia Virus (MoMLV) requires interaction with peptidyl release factor 1. Here, the authors report the crystal structure of this complex, and provide insights into how MoMLV uses the host translation machinery to synthesize its own proteins.
Guardado en:
Autores principales: | Xuhua Tang, Yiping Zhu, Stacey L. Baker, Matthew W. Bowler, Benjamin Jieming Chen, Chen Chen, J. Robert Hogg, Stephen P. Goff, Haiwei Song |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7f530fbe22d7490e8ba014489e46d784 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Compounds that enhance the tailing activity of Moloney murine leukemia virus reverse transcriptase
por: Yoshiyuki Ohtsubo, et al.
Publicado: (2017) -
Characterization of the long-terminal repeat single-strand tail-binding site of Moloney-MuLV integrase by crosslinking
por: VERA,JORGE, et al.
Publicado: (2008) -
The structural basis for release-factor activation during translation termination revealed by time-resolved cryogenic electron microscopy
por: Ziao Fu, et al.
Publicado: (2019) -
TCP1 increases drug resistance in acute myeloid leukemia by suppressing autophagy via activating AKT/mTOR signaling
por: Xiaofang Chen, et al.
Publicado: (2021) -
Selective inhibition of human translation termination by a drug-like compound
por: Wenfei Li, et al.
Publicado: (2020)